Trasylol (Aprotinin) May Cause Fatal Side Effects: Information for patients

by John McKiggan

We have been investigating potential personal injury claims against Bayer Inc. the manufacturer of the drug Trasylol (Aprotinin) for almost a year now.

In January 2006, the New England Journal of Medicine reported that of the 4,400 heart surgery patients who received Trasylol:

1. Trasylol increased the risk of stroke by 181%;

2. Trasylol increased the risk of heart attack by 48%; and

3. Trasylol increased the risk of heart failure by 109%.

Furthermore, in a Canadian Research Study referred to as the BART Study, Trasylol was compared to alternative health surgery drugs. The BART Study found that 1 in 50 patients who received Trasylol died from complications related to the drug.

Some patients at the cardiac unit of the Queen Elizabeth II Health Sciences Centre in Halifax Nova Scotia received Trasylol as part of the hospital’s pre-operative procedures. There are no public statistics about how many patients from the Queen Elizabeth II Health Sciences Centre received Trasylol or how many of those patients who received Trasylol developed debilitating or fatal complications.

If you or a family member had heart surgery at the Queen Elizabeth II Health Sciences Centre and suffered stroke, heart attack, heart failure or kidney damage after your surgery, you may have a potential claim for compensation.

If you are think you or a family member has suffered a brain injury as a result of an accident and require the services of a Brain Injury Lawyer you can contact me through my website, or call toll-free 1-877-891-1664, for a free consultation or to request a free copy of my book: The Survivor’s Guide to Brain Injury Claims: How to prove the “invisible injury”.

Comments are closed.